- Home
- NMS vs PYXS Comparison
NMS vs PYXS Comparison
Compare NMS & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMS
- PYXS
- Stock Information
- Founded
- NMS 1993
- PYXS 2018
- Country
- NMS United States
- PYXS United States
- Employees
- NMS N/A
- PYXS N/A
- Industry
- NMS Finance Companies
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- NMS Finance
- PYXS Health Care
- Exchange
- NMS Nasdaq
- PYXS Nasdaq
- Market Cap
- NMS 68.7M
- PYXS 64.4M
- IPO Year
- NMS N/A
- PYXS 2021
- Fundamental
- Price
- NMS $11.70
- PYXS $1.07
- Analyst Decision
- NMS
- PYXS Strong Buy
- Analyst Count
- NMS 0
- PYXS 6
- Target Price
- NMS N/A
- PYXS $9.20
- AVG Volume (30 Days)
- NMS 12.0K
- PYXS 527.2K
- Earning Date
- NMS 01-01-0001
- PYXS 05-20-2025
- Dividend Yield
- NMS 4.11%
- PYXS N/A
- EPS Growth
- NMS N/A
- PYXS N/A
- EPS
- NMS N/A
- PYXS N/A
- Revenue
- NMS N/A
- PYXS $16,146,000.00
- Revenue This Year
- NMS N/A
- PYXS N/A
- Revenue Next Year
- NMS N/A
- PYXS N/A
- P/E Ratio
- NMS N/A
- PYXS N/A
- Revenue Growth
- NMS N/A
- PYXS N/A
- 52 Week Low
- NMS $9.21
- PYXS $0.83
- 52 Week High
- NMS $12.18
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- NMS 47.27
- PYXS 49.93
- Support Level
- NMS $11.43
- PYXS $1.05
- Resistance Level
- NMS $11.84
- PYXS $1.33
- Average True Range (ATR)
- NMS 0.11
- PYXS 0.10
- MACD
- NMS 0.02
- PYXS 0.01
- Stochastic Oscillator
- NMS 65.85
- PYXS 23.53
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.